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B ronchopleural fistula (BPF) is one of the serious potential complications following lung resection.  
Its incidence is reported to be 4.5-14.3% after pneumo-
nectomy and 0.6-1.4% after lobectomy [1-4].  The 
reported mortality rate for BPF ranges from 11.1% to 
71.2%,  and BPF still represents a therapeutic challenge 
for thoracic surgeons [1 , 2].  The most common cause of 
death among patients with a BPF is aspiration pneumo-
nia with subsequent adult respiratory distress syndrome 
(ARDS).  The risk factors for BPF are known; they 
include pneumonectomy,  right-sided procedures,  
residual tumor on the bronchial stump,  advanced age,  
male sex,  diabetes,  steroid therapy,  preoperative radio-
therapy,  and perioperative infections [1 , 5 , 6].
The incidence of BPF peaks in the second or third 
postoperative week.  The mortality rate of early BPF (i.e.,  
BPF that occurs within 30 days after lung resection) was 
found to be higher than that of late BPF [7].  Surgical 
intervention has been an established therapy for BPF,  
but an endoscopic procedure is the alternative for the 
closure of the fistula to avoid major surgery [8].  We 
analyzed the therapeutic outcomes of BPF at our insti-
tution to determine the optimal approach.
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Therapeutic approaches to bronchopleural fistula (BPF) closure after lung resection are surgical or endoscopic 
interventions.  We evaluated therapeutic outcomes to determine the optimal approach.  We reviewed 15 patients 
who had developed BPF after lung resection for thoracic malignant diseases at our institution in the 10 years 
since 2008.  The patients were 11 men and 4 women (mean age 68 years).  We performed one pneumonectomy,  
6 lobectomies,  7 segmentectomies,  and one partial resection for malignant diseases.  The median interval from 
lung resection to the BPF diagnosis was 46 days.  The BPF-associated mortality rate was 26.7% (4/15).  The rate 
of successful BPF closure was 66.6% (10/15).  The endoscopic and surgical intervention success rates were 14.2% 
(1/7) and 69.2% (9/13),  respectively (p< 0.01).  Of 5 patients who had failed BPF treatments,  4 died,  and one 
transferred out without BPF closure.  The therapeutic outcomes were related to preoperative comorbidities,  
performance status at the BPF diagnosis,  time intervals from lung resection to BPF diagnosis,  and presence of 
active pneumonia.  The difference between endoscopic and surgical outcomes was nonsignificant,  although the 
surgical intervention success rate was somewhat higher.  The selection of endoscopic or surgical intervention for 
BPF does not significantly affect therapeutic outcomes.
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Patients and Methods
Fifteen patients underwent an endoscopic or surgical 
intervention for a postoperative BPF at the Shikoku 
Cancer Center between January 2008 and December 
2017.  The clinicopathologic data of these patients 
including their sex,  age,  performance status (PS) at the 
time of lung resection,  primary disease,  pathological 
stage,  smoking history,  comorbidities,  preoperative 
treatment,  extent and site of operation,  technique of 
bronchial stump closure,  use of reinforcement,  and 
postoperative complications were collected.  The TNM 
stage of lung cancer was estimated based on the eighth 
edition of the Lung Cancer Stage Classification.  The 
information about BPF including the PS at the time of 
diagnosis,  the time intervals from the lung resection to 
the diagnosis of BPF,  the sizes of the fistulas,  the pres-
ence of active pneumonia,  infection of pleural effusion,  
therapeutic approaches,  and outcomes were collected.  
In all patients,  the diagnosis of BPF was confirmed by 
using bronchoscopy.  We measured the size of each BPF 
in comparison to the diameter of the bronchoscope.
Endoscopic intervention was performed using a 
flexible bronchoscope.  We used fibrin or cyanoacrylate 
glue,  polyglycolic acid (PGA) sheet,  an endobronchial 
Watanabe spigot (EWS),  or silver nitrate to close the 
fistula.  In the surgical intervention,  the pedicled 
omentum or muscle flap was sutured to or eased into 
the edges of the BPF.  Success was defined as the visual 
closure of the BPF without any air leak and the dis-
charge of the patient without an in situ drain.
We used the JMP software program (SAS,  Cary,  
NC,  USA) for calculations,  and the analysis was per-
formed with log-rank statistics.  The study was approved 
by the Institutional Review Board at the Shikoku Cancer 
Center,  Matsuyama.  Informed consent was not 
required for this retrospective study.
Results
Patient characteristics. The patient characteris-
tics are summarized in Table 1.  The patients were 11 
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Table 1　 Patient characteristics
Characteristics n=15
Gender Surgical approach
　Male/female 11/4 　Thoracotomy 7
Age 　Videothorcoscopy 8
　Mean (SD),  years 68 (6.7) Operative procedure and location
PS＊ 　Pneumonectomy＊＊ 1
　0/1 14/1 　　Right 1
Primary disease 　Lobectomy 6
　NSCLC 12 　　RU/RL 2/4
　Metastic LC 2 　Segmentectomy 7
　MPM 1 　　RU/RL/LU/LL 1/1/3/2
NSCLC 　Sublobar resection 1
　pStage I/II/III 7/3/2 　　RU 1
　Pathology Ad/Sq 11/1 Reinforcement 1
Smoking history 13 Postoperative complication＊＊＊
Past history of lung resection 6 　Prolonged air leakage 5
Comorbidity 　Pneumonia 5
　Emphysema 4 　Empyema 2
　Tuberculosis 1 　Atelectasis 1
　Rheumatism 1 　Pulmonary torsion 1
Preoperative therapy 　AMI 1
　Chemotherapy 1 Interval to the diagnosis of BPF＊＊＊＊
　Median (range),  days 46 (12-1,123)
BPFs were more frequently observed in the right lower lobes (33.3%,  5/15).  Ad,  adenocarcinoma; AMI,  acute myocardial infarction;  
BPF,  bronchopleural ﬁstula; LL,  left lower; LU,  left upper; NSCLC,  non-small cell lung cancer; PS,  performance status; RL,  right low-
er; RU,  right upper; SD,  standard deviation; Sq,  squamous cell carcinoma; PS＊,  PS at the time of lung resection; Pneumonectomy＊＊,  
Extra-pleural pneumonectomy; Postoperative complication＊＊＊,  Postoperative complications at the ﬁrst surgery; Interval to the diagnosis of 
BPF＊＊＊＊,  The time interval from the lung resection to the diagnosis of BPF.
men and four women with the mean age of 68 ± 6.7 
years.  The primary disease at the initial operation was 
primary lung cancer in 12 patients,  metastatic lung 
cancer in 2 (derived from primary colon cancer or sub-
mandibular gland cancer),  and malignant pleural 
mesothelioma (MPM) in one.  Six patients had previ-
ously undergone a pulmonary resection,  because of 
metachronous primary lung cancers in 5 patients and 
lung metastases of submandibular gland cancer in the 
remaining patient.  The patient with MPM had received 
preoperative chemotherapy with cisplatin and peme-
trexed.
The therapeutic approaches in these cases were one 
pneumonectomy (extra-pleural pneumonectomy),  6 
lobectomies,  7 segmentectomies,  and one large sublo-
bar resection.  Right-sided resection was more frequent 
than left-sided (10 vs. 5).  BPFs were more frequently 
observed in the right lower lobes (33.3%,  5/15).  We 
used staples for bronchial closure in 14 patients; the 
other was the patient who underwent sublobar resec-
tion.  In the single patient who underwent a pneumo-
nectomy,  the bronchial stump was covered with peri-
cardial fat.  One patient developed pulmonary torsion of 
the residual left upper division segment after a lingual 
segmentectomy,  and he underwent a completion lobec-
tomy.  The median interval to the diagnosis of BPF after 
lung resection was 46 days (12-1,123 days).
Endoscopic and surgical interventions. The suc-
cess rate of BPF closure was 66.6% (10/15).  The mortal-
ity rate associated with BPF was 26.7% (4/15).  Table 2 
lists the therapeutic treatments and outcomes of BPF.  
We administered antibiotics and inserted the chest tube 
for all patients before treating their BPFs.  We per-
formed endoscopic interventions in 7 patients and sur-
gical interventions in 13 patients.  The success rates of 
the endoscopic and surgical interventions were 14.2% 
(1/7) and 69.2% (9/13),  respectively (p < 0.01).  
Endoscopic intervention was successful in only one 
patient,  which was performed with cyanoacrylate glue.  
We often used fibrin glue (5/7) and PGA sheet (3/7).
Of the 13 patients who underwent surgical interven-
tion,  9 underwent BPF closure with a pedicled omen-
tum or muscle flap.  One patient underwent only wound 
closure after an open-window thoracostomy because the 
BPF closed spontaneously.  Another patient with BPF 
after a right lower lobectomy successfully underwent a 
completion middle and lower lobectomy.  Two patients 
were unable to undergo BPF closure because of a poor 
nutritional status and physical condition after an 
open-window thoracostomy.  Of the 5 patients who 
failed BPF treatments,  2 died of aspiration pneumonia 
with ARDS,  one died of respiratory failure with narco-
sis 31 days after surgical intervention.  One patient for 
whom we were unable to perform any intervention died 
of an acute myocardial infarction.  One patient trans-
ferred to another hospital for rehabilitation without BPF 
closure because of the development of a cerebral infarc-
tion with subsequent hemiplegia.  After a few years,  3 
patients died of primary or other cancers,  although 
they overcame their BPFs.
Important factors of the successful therapeutic out-
come of BPF. Table 3 compares the patient charac-
teristics and therapeutic outcomes between the patients 
who were successfully treated and those who failed.  
Preoperative comorbidities,  poor PS at the time of the 
diagnosis of BPF,  a short interval from the resection to 
the diagnosis of BPF,  and the presence of active pneu-
monia each had a negative impact on therapeutic out-
comes.  No significant difference in outcomes was 
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Table 2　 Therapeutic approaches and outcomes of bronchopleu-
ral ﬁstulas (BPFs)
n=15
Endoscopic intervention 7
　Success rate (%) 1 (14.2%)
　Material
　　Fibrin glue 5
　　PGA sheet 3
　　EWS 2
　　Cyanoacrylate glue 1
　　Others 2
　Frequency
　　Median (range) 2 (1-4)
Surgical intervention 13
　Success rate (%) 9 (69.2%)
　Operative procedure
　　Pedicled omentopexy 7
　　Pedicled muscle ﬂap 2
　　Others 2
　　Only OWT 2
Death (%) 4 (26.7%)
　Aspiration pneumonia 2
　Respiratory failure 1
　AMI 1
The success rates of the endoscopic and surgical interventions 
were 14.2% (1/7) and 69.2% (9/13),  respectively (p＜0.01).  The 
mortality rate was 26.7% (4/15).  AMI,  acute myocardial infarction;  
EWS,  endobronchial Watanabe spigot; OWT,  open-window tho-
racostomy; PGA,  polyglycolic acid.
detected between the endoscopic and surgical interven-
tion groups.  Table 4 compares the patient characteris-
tics and therapeutic outcomes between the patients with 
and without endoscopic intervention.  No significant 
differences were shown in any factors.  The selection of 
an endoscopic or surgical intervention showed no asso-
ciation with the therapeutic outcome.
Discussion
In the 10 years since 2008,  we performed 1,976 lung 
resections for malignant lung disease such as primary 
and metastatic lung cancers and mesotheliomas at our 
institution.  The incidence of BPF was 3.6% (1/28) after 
pneumonectomy,  0.4% (6/1,300) after lobectomy,  2.2% 
(7/314) after segmentectomy,  and 0.3% (1/334) after 
sublobar resection.  These results are consistent with the 
literature [1-4].  Right-sided pneumonectomy and right 
lower lobectomy are known to be associated with a high 
risk of BPF [2-4].  In the present study,  a patient who 
had undergone a pneumonectomy had a right-sided 
bronchial fistula,  and 4 of the 6 patients who had 
undergone a lobectomy had a BPF after a right lower 
lobectomy (66.6%).  In the 7 segmentectomies and the 
single sublobar resection,  the locations of BPF were 
dispersed.
Sonobe et al.  reported that patients who had under-
gone a previous ipsilateral thoracotomy had a signifi-
cantly higher incidence of BPF because of poor vascu-
larity to the bronchial stump [3].  In the present study,  
2 of the 6 patients with the previous thoracotomy 
underwent an ipsilateral lung resection.  Likewise,  
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Table 3　 Comparison of the patients who were successfully treated and those who failed
Success n=10 Failure n=5 p
Gender
　Male/female 6/4 5/0 0.10
Age
　Mean (SD),  years 66 (5.5) 72 (6.7) 0.07
PS＊
　0-2/3,  4 8/2 1/4 0.03
Smoking history 8 5 0.28
Past history of lung resection 4 2 1.00
Comorbidity
　Emphysema 1 3 0.03
　Tuberculosis 1
　Rheumatism 1
Primary operation
　Pneumonectomy and Lobectomy 5 2 0.71
　Segmentectomy and Sublobar resection 5 3
Operative side
　Right/left 7/3 4/1 0.70
Interval to the diagnosis of BPF＊＊
　Median (range),  days 144 (23-1,123) 16 (12-75) 0.02
Size of BPF
　Small (≤3 mm) 4 1 0.71
　Intermediate (＞3 and ≤6 mm) 4 3
　Large (＞6 mm) 2 1
Active pneumonia (%) 2 (20%) 5 (100%) 0.003
Positive infection of pleural eﬀusion (%) 3 (30%) 1 (20%) 0.68
BPF treatment
　Endoscopic intervention 5 2 0.59
　Surgical intervention 9 4 0.71
Death 0 4 0.001
The therapeutic outcome was related to preoperative comorbidities,  the PS at the time of the diagnosis of BPF,  the time interval from the 
lung resection to the diagnosis of BPF and the presence of active pneumonia; PS,  performance status; PS＊,  PS at the time of diagnosis 
of BPF; Interval to the diagnosis of BPF＊＊,  The time interval from the lung resection to the diagnosis of BPF.
another patient developed a left lower BPF after 2 ipsi-
lateral segmentectomies at the left upper division and 
S8+9 for metachronous lung cancer.  Maintaining an 
adequate blood supply to the bronchial stump is a key 
factor in preventing BPFs.
Our analysis revealed that poor PS,  the presence of 
preoperative comorbidities,  a short interval between the 
lung resection and the diagnosis of BPF,  and the pres-
ence of active pneumonia each had a negative impact on 
the therapeutic outcomes.  We were thus unable to res-
cue the high-risk patients with active pneumonia.  Peter 
et al.  reported that the incidence of aspiration pneumo-
nia dropped as the time interval between the operation 
and the fistula onset increased,  and death from aspira-
tion pneumonia was avoided when the fistula appeared 
≥ 3 months after surgery.  Jichen et al.  reported that 
different treatments should be used for early and late 
BPFs because the mortality rate of early BPFs was sig-
nificantly higher [7].  In the 2 present patients who died 
of active pneumonia,  the time intervals between the 
lung resection and the diagnosis of BPF were 12 and 16 
days,  respectively.  The selection of an endoscopic 
intervention or a surgical intervention had no signifi-
cant impact on the therapeutic outcomes.  It was more 
important to evaluate each patient’s condition and con-
trol his/her pneumonia.
Some reports show that endoscopic intervention is 
useful and safe [4 , 8 , 9].  Conservative management is 
reported to be useful in post-lobectomy fistulas that are 
almost completely closed after the positioning of a chest 
tube for drainage.  Endoscopic intervention associated 
with conservative therapy should be considered a safe 
and useful option [4].  If the patient’s physical condition 
is stable,  an endoscopic intervention might be effective.
One of the present patients underwent an endo-
scopic intervention that supported a surgical interven-
tion; we diagnosed his BPF at 281 days after a segmen-
tectomy of the left upper division.  He had no pneumonia 
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Table 4　 Comparison between the patients with and without endoscopic intervention
Endoscopic intervention
Yes (n=7) No (n=7) p
Gender
　Male/female 5/2 5/2 1.00
Age
　Mean (SD),  years 69 (5.7) 68 (7.8) 0.78
PS＊
　0-2/3,  4 5/2 3/4 0.58
Smoking history (%) 5 (71%) 7 (100%) 0.13
Past history of lung resection 4 2 0.28
Comorbidity 1 3 0.58
Primary operation
　Pneumonectomy and Lobectomy 2 4 0.28
　Segmentectomy and Sublobar resection 5 3
Operative side
　Right/left 4/3 5/2 0.58
Interval to the diagnosis of BPF＊＊
　Median (range),  days 160 (29-513) 37 (12-1,123) 0.98
Size of BPF
　Small (≤3 mm) 4 1 0.10
　Intermediate (＞3 and ≤6 mm) 3 3
　Large (＞6 mm) 0 3
Active pneumonia 2 4 0.28
Positive infection of pleural eﬀusion (%) 2 1 0.51
Success of BPF treatment 5 5 1.00
Death 1 2 0.51
No signiﬁcant diﬀerences in patient characteristics or therapeutic outcomes were revealed between the patients with and without endo-
scopic intervention.  PS＊,  PS at the time of the diagnosis of BPF; Interval to the diagnosis of BPF＊＊,  The time interval from the lung 
resection to the diagnosis of BPF.
and his PS was 1.  First,  the endoscopic interventions 
with an EWS failed twice,  and then an open-window 
thoracotomy was performed.  The EWS successfully 
filled the left B1+2 fistula with the use of the push-and-
slide method in which a guide wire is inserted through 
the fistula with bronchoscopy,  and an EWS through 
which the wire penetrates is pushed into the fistula with 
a catheter (Fig. 1).  We easily held the end of the wire 
projecting from the BPF in the chest cavity of the open 
window.  Negative pressure wound therapy was per-
formed for 1 month to minimize the cavity,  which was 
then filled using pedicle omentopexy.
Our failure of endoscopic intervention may be partly 
because of our procedure for BPF closure.  We often put 
some cut and rolled PGA sheets into a BPF with fibrin 
glue (Fig. 2).  Although this patient’s air leakage had 
disappeared for a few days,  it developed again because 
the sheets were dislodged whenever the patient 
coughed.
Fuso et al.  recommend cyanoacrylate glue rather 
than fibrin glue because the cyanoacrylate glue polym-
erizes quickly into a thin elastic film and adheres firmly 
330 Ueno et al. Acta Med.  Okayama　Vol.  73,  No.  4
B3
B1+2
B1+2
Catheter
a b
Fig. 1　 a:  Left B1+2 bronchial ﬁstula.  An endobronchial Watanabe spigot (EWS) successfully ﬁlled the ﬁstula with the push-and-slide 
method in which a guide wire is inserted through the ﬁstula with bronchoscopy,  and an EWS (white arrow) through which the wire pene-
trates is pushed into the ﬁstula with a catheter (b).
B8-10B
6
B6
B8-10
a b
Fig. 2　 After a polyglycolic acid (PGA) sheet was cut into pieces and rolled,  it was inserted into the B6 ﬁstula (a) and stabilized with ﬁbrin 
glue (b).
to the tissue [4].  Indeed,  cyanoacrylate glue was used in 
our successful endoscopic intervention.  According to 
the size,  depth,  and location of a BPF,  an adequate 
filling material and/or method should be selected.
In summary,  the selection of endoscopic interven-
tion or surgical intervention for BPF did not affect the 
therapeutic outcomes.  This study’s main limitation is its 
retrospective design.
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